Administration of dendritic cells dual expressing DcR3 and GAD65 mediates the suppression of T cells and induces long-term acceptance of pancreatic-islet transplantation

Vaccine

Volumn 28, Issue 52, 2010, Pages 8300-8305

  Li, Qiansheng ^a   Ge, Chengguo ^a   Liu, Rongrong ^a   Zhang, Keqin ^a   Wu, Gang ^a   Huo, Wenqian ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

DcR3; Dendritic cells; GAD65; Pancreatic islet transplantation

Indexed keywords

ADENOVIRUS VECTOR; DECOY RECEPTOR 3; GLUTAMATE DECARBOXYLASE 65;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ADENOVIRIDAE; ANIMALS; DENDRITIC CELLS; FEMALE; GENETIC VECTORS; GLUTAMATE DECARBOXYLASE; GRAFT REJECTION; HUMANS; IMMUNE TOLERANCE; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED NOD; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; T-LYMPHOCYTES; TRANSFECTION;

EID: 78649759350     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.09.094     Document Type: Article

References (43)

1. Huurman V.A., Hilbrands R., Pinkse G.G., Gillard P., Duinkerken G., van de Linde P., et al. Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation. PLoS ONE 2008, 3:e2435.
2. Tian C., Ansari M.J., Paez-Cortez J., Bagley J., Godwin J., Donnarumma M., et al. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy. J Immunol 2007, 179:6762-6769.
3. Balamurugan A.N., Bottino R., Giannoukakis N., Smetanka C. Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes. Pancreas 2006, 32:231-243.
4. Stegall M.D., Lafferty K.J., Kam I., Gill R.G. Evidence of recurrent autoimmunity in human allogeneic islet transplantation. Transplantation 1996, 61:1272-1274.
5. Okitsu T., Bartlett S.T., Hadley G.A., Drachenberg C.B., Farney A.C. Recurrent autoimmunity accelerates destruction of minor and major histoincompatible islet grafts in nonobese diabetic (NOD) mice. Am J Transplant 2001, 1:138-145.
6. Bach J.F., Chatenoud L. Tolerance to islet autoantigens in type 1 diabetes. Annu Rev Immunol 2001, 19:131-161.
7. Cooke A., Phillips J.M., Parish N.M. Tolerogenic strategies to halt or prevent type 1 diabetes. Nat Immunol 2001, 2:810-815.
8. Palmer J.P., Asplin C.M., Clemons P., Lyen K., Tatpati O., Raghu P.K., et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983, 222:1337-1339.
9. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., et al. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990, 347:151-156.
10. Elias D., Markovits D., Reshef T., van der Zee R., Cohen I.R. Induction and therapy of autoimmune diabetes in the non-obese diabetic (NOD/Lt) mouse by a 65-kDa heat shock protein. Proc Natl Acad Sci USA 1990, 87:1576-1580.
11. Lieberman S.M., Evans A.M., Han B., Takaki T., Vinnitskaya Y., Caldwell J.A., et al. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc Natl Acad Sci USA 2003, 100:8384-8388.
12. Tisch R., Yang X.D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 1993, 366:72-75.
13. Wegmann D.R., Gill R.G., Norbury-Glaser M., Schloot N., Daniel D. Analysis of the spontaneous T cell response to insulin in NOD mice. J Autoimmun 1994, 7:833-843.
14. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S., Robinson P., et al. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 1993, 366:69-72.
15. Pitti R.M., Marsters S.A., Lawrence D.A., Roy M., Kischkel F.C., Dowd P., et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 1998, 396:699-703.
16. Yu K.Y., Kwon B., Ni J., Zhai Y., Ebner R., Kwon B.S. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem 1999, 274:13733-13736.
17. Migone T.S., Zhang J., Luo X., Zhuang L., Chen C., Hu B., et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002, 16:479-492.
18. Chervonsky A.V., Wang Y., Wong F.S., Visintin I., Flavell R.A., Janeway C.A., et al. The role of Fas in autoimmune diabetes. Cell 1997, 89:17-24.
19. Su X., Hu Q., Kristan J.M., Costa C., Shen Y., Gero D., et al. Significant role for Fas in the pathogenesis of autoimmune diabetes. J Immunol 2000, 164:2523-2532.
20. Ettinger R., Munson S.H., Chao C.C., Vadeboncoeur M., Toma J., McDevitt H.O. A critical role for lymphotoxin-beta receptor in the development of diabetes in nonobese diabetic mice. J Exp Med 2001, 193:1333-1340.
21. Wu Q., Salomon B., Chen M., Wang Y., Hoffman L.M., Bluestone J.A., et al. Reversal of spontaneous autoimmune insulitis in nonobese diabetic mice by soluble lymphotoxin receptor. J Exp Med 2001, 193:1327-1332.
22. Juang J.H., Kuo C.H., Hsu B.R. Effects of multiple site implantation on islet transplantation. Transplant Proc 2002, 34:2698-2699.
23. DiLorenzo T.P., Serreze D.V. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice. Immunol Rev 2005, 204:250-263.
24. Graser R.T., DiLorenzo T.P., Wang F., Christianson G.J., Chapman H.D., Roopenian D.C., et al. Identification of a CD8 T cell that can independently mediate autoimmune diabetes development in the complete absence of CD4 T cell helper functions. J Immunol 2000, 164:3913-3918.
25. Wong F.S., Visintin I., Wen L., Flavell R.A., Janeway C.A. CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells. J Exp Med 1996, 183:67-76.
26. Verdaguer J., Schmidt D., Amrani A., Anderson B., Averill N., Santamaria P. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J Exp Med 1997, 186:1663-1676.
27. Wang B., Gonzalez A., Benoist C., Mathis D. The role of CD8+ T cells in the initiation of insulin-dependent diabetes mellitus. Eur J Immunol 1996, 26:1762-1769.
28. Sumida T., Furukawa M., Sakamoto A., Namekawa T., Maeda T., Zijlstra M., et al. Prevention of insulitis and diabetes in beta 2-microglobulin-deficient non-obese diabetic mice. Int Immunol 1994, 6:1445-1449.
29. Serreze D.V., Leiter E.H., Christianson G.J., Greiner D., Roopenian D.C. Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 1994, 43:505-509.
30. Wicker L.S., Leiter E.H., Todd J.A., Renjilian R.J., Peterson E., Fischer P.A., et al. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 1994, 43:500-504.
31. Hamilton-Williams E.E., Palmer S.E., Charlton B., Slattery R.M. Beta cell MHC class I is a late requirement for diabetes. Proc Natl Acad Sci USA 2003, 100:6688-6693.
32. Itoh N., Hanafusa T., Miyazaki A., Miyagawa J., Yamagata K., Yamamoto K., et al. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J Clin Invest 1993, 92:2313-2322.
33. Somoza N., Vargas F., Roura-Mir C., Vives-Pi M., Fernandez-Figueras M.T., Ariza A., et al. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile. J Immunol 1994, 153:1360-1377.
34. Santamaria P., Nakhleh R.E., Sutherland D.E., Barbosa J.J. Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes 1992, 41:53-61.
35. Bai C., Connolly B., Metzker M.L., Hilliard C.A., Liu X., Sandig V., et al. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci USA 2000, 97:1230-1235.
36. Zhang J., Salcedo T.W., Wan X., Ullrich S., Hu B., Gregorio T., et al. Modulation of T-cell responses to alloantigens by TR6/DcR3. J Clin Invest 2001, 107:1459-1468.
37. Han B., Wu J. DcR3 protects islet beta cells from apoptosis through modulating Adcyap1 and Bank1 expression. J Immunol 2009, 183:8157-8166.
38. Sung H.H., Juang J.H., Lin Y.C., Kuo C.H., Hung J.T., Chen A., et al. Transgenic expression of decoy receptor 3 protects islets from spontaneous and chemical-induced autoimmune destruction in nonobese diabetic mice. J Exp Med 2004, 199:1143-1151.
39. Tokita D., Mazariegos G.V., Zahorchak A.F., Chien N., Abe M., Raimondi G., et al. High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation 2008, 85:369-377.
40. Ohnmacht C., Pullner A., King S.B., Drexler I., Meier S., Brocker T., et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med 2009, 206:549-559.
41. Villadangos J.A., Schnorrer P. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol 2007, 7:543-555.
42. Yang S., Li W., Liu W., Gao C., Zhou B., Li S., et al. IL-10 gene modified dendritic cells induced antigen-specific tolerance in experimental autoimmune myocarditis. Clin Immunol 2006, 121:63-73.
43. Menges M., Rossner S., Voigtlander C., Schindler H., Kukutsch N.A., Bogdan C., et al. Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. J Exp Med 2002, 195:15-21.